CYCLOSPORINE-A BLOCKS BILE-ACID SYNTHESIS IN CULTURED-HEPATOCYTES BY SPECIFIC-INHIBITION OF CHENODEOXYCHOLIC ACID SYNTHESIS

被引:113
作者
PRINCEN, HMG
MEIJER, P
WOLTHERS, BG
VONK, RJ
KUIPERS, F
机构
[1] UNIV GRONINGEN,DEPT PEDIAT,9712 KZ GRONINGEN,NETHERLANDS
[2] STATE UNIV GRONINGEN HOSP,CENT LAB CLIN CHEM,9713 EZ GRONINGEN,NETHERLANDS
关键词
D O I
10.1042/bj2750501
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bile acid synthesis, determined by conversion of [4-C-14]cholesterol into bile acids in rat and human hepatocytes and by measurement of mass production of bile acids in rat hepatocytes, was dose-dependently decreased by cyclosporin A, with 52% (rat) and 45% (human) inhibition at 10-mu-M. The decreased bile acid production in rat hepatocytes was due only to a fall in the synthesis of beta-muricholic and chenodeoxycholic acids (-64% at 10-mu-M-cyclosporin A), with no change in the formation of cholic acid. In isolated rat liver mitochondria, 26-hydroxylation of cholesterol was potently inhibited by the drug (concn. giving half-maximal inhibition = 4-mu-M). These results suggest that cyclosporin A blocks the alternative pathway in bile acid synthesis, which leads preferentially to the formation of chenodeoxycholic acid.
引用
收藏
页码:501 / 505
页数:5
相关论文
共 40 条
[21]  
KAHAN BD, 1989, NEW ENGL J MED, V321, P1725
[22]  
KAHAN BD, 1983, TRANSPLANT P, V15, P446
[23]  
KEMPEN HJM, 1982, J LIPID RES, V23, P823
[24]   INHIBITION AND INDUCTION OF BILE-ACID SYNTHESIS BY KETOCONAZOLE - EFFECTS ON BILE FORMATION IN THE RAT [J].
KUIPERS, F ;
HAVINGA, R ;
HUIJSMANS, CMG ;
VONK, RJ ;
PRINCEN, HMG .
LIPIDS, 1989, 24 (09) :759-764
[25]   CHOLESTEROL 7-ALPHA-HYDROXYLASE ACTIVITY AND BILE-ACID SYNTHESIS IN HEPATOCYTES OF UNWEANED AND WEANED PIGS IN MONOLAYER-CULTURE [J].
KWEKKEBOOM, J ;
PRINCEN, HMG ;
VANVOORTHUIZEN, EM ;
KEMPEN, HJM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1042 (03) :386-394
[26]   IS CYCLOSPORINE-A AN INHIBITOR OF DRUG-METABOLISM [J].
LI, G ;
TREIBER, G ;
MEINSHAUSEN, J ;
WOLF, J ;
WERRINGLOER, J ;
KLOTZ, U .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (01) :71-77
[27]  
LOKIEC F, 1983, TRANSPLANT P, V15, P2442
[28]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[29]  
MAURER G, 1984, DRUG METAB DISPOS, V12, P120
[30]  
MITROPOULOS K A, 1972, Biochemical Journal, V130, P363